• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对比增强计算机断层扫描评估的颈部淋巴结密度在接受热疗和放疗的头颈部鳞状细胞癌中的预后意义

Prognostic significance of cervical lymph nodes density evaluated by contrasted computer tomography in head and neck squamous cell carcinoma treated with hyperthermia and radiotherapy.

作者信息

Amichetti M, Zurlo A, Cristoforetti L, Valdagni R

机构信息

Department of Radiation Oncology of S. Chiara Hospital, Trento, Italy.

出版信息

Int J Hyperthermia. 2000 Nov-Dec;16(6):539-47. doi: 10.1080/02656730050199377.

DOI:10.1080/02656730050199377
PMID:11129264
Abstract

INTRODUCTION

A correlation between node hypodensity assessed by means of computer tomography (CT) and resistance to both chemotherapy and radiation therapy (XRT) in advanced head and neck tumours has been suggested in the literature. The outcome of a retrospective series of 50 patients with head and neck squamous cell carcinoma (SCC) and cervical nodes metastases treated with combined hyperthermia (HT) and definitive XRT was reviewed to investigate if node density confirmed its prognostic value.

MATERIALS AND METHOD

For all patients, a pre-treatment contrasted CT scan performed at the Institution between 1987-1993 was available. The density of the largest node (> 2cm) was compared to that of adjacent nuchal muscles. Nodes with hypodense areas present in more than one third of the total volume were considered necrotic nodes.

RESULTS

The patients were divided in two groups (with and without nodal necrosis), well balanced in terms of potential prognostic factors. No significant difference in overall nodal response rate, local control and survival was found in the two groups of patients.

CONCLUSION

Nodal density assessed by contrasted CT scan in the series did not result in a significant prognostic factor in patients with SCC node metastases treated with HT and XRT. It is suggested that HT could act as a radiosensitizer in the treatment of hypodense (at CT scan) metastatic nodes overcoming the radioresistance of necrotic, presumably hypoxic nodal metastases.

摘要

引言

文献中已提出通过计算机断层扫描(CT)评估的淋巴结低密度与晚期头颈部肿瘤对化疗和放射治疗(XRT)的抵抗之间存在相关性。回顾了一组50例头颈部鳞状细胞癌(SCC)伴颈部淋巴结转移患者接受热疗(HT)联合根治性XRT治疗的回顾性系列研究结果,以调查淋巴结密度是否证实其预后价值。

材料与方法

对于所有患者,均有1987 - 1993年间在该机构进行的治疗前增强CT扫描资料。将最大淋巴结(> 2cm)的密度与相邻颈部肌肉的密度进行比较。总容积中超过三分之一区域存在低密度区的淋巴结被视为坏死淋巴结。

结果

患者分为两组(有和无淋巴结坏死),在潜在预后因素方面均衡良好。两组患者在总体淋巴结反应率、局部控制率和生存率方面未发现显著差异。

结论

在该系列研究中,通过增强CT扫描评估的淋巴结密度在接受HT和XRT治疗的SCC淋巴结转移患者中并非显著的预后因素。提示HT在治疗CT扫描显示为低密度的转移性淋巴结时可作为放射增敏剂,克服坏死的、可能缺氧的淋巴结转移灶的放射抵抗。

相似文献

1
Prognostic significance of cervical lymph nodes density evaluated by contrasted computer tomography in head and neck squamous cell carcinoma treated with hyperthermia and radiotherapy.对比增强计算机断层扫描评估的颈部淋巴结密度在接受热疗和放疗的头颈部鳞状细胞癌中的预后意义
Int J Hyperthermia. 2000 Nov-Dec;16(6):539-47. doi: 10.1080/02656730050199377.
2
Correlation of Computerized Tomography density patterns of lymph nodes with treatment results and outcome in head and neck cancer patients treated by 2 different chemoradiotherapy schedules.采用两种不同放化疗方案治疗的头颈癌患者中,淋巴结的计算机断层扫描密度模式与治疗结果及预后的相关性
J Cancer Res Ther. 2014 Apr-Jun;10(2):284-93. doi: 10.4103/0973-1482.136566.
3
Computed tomographic density of metastatic lymph nodes as a treatment-related prognostic factor in advanced head and neck cancer.转移性淋巴结的计算机断层扫描密度作为晚期头颈癌的治疗相关预后因素
J Natl Cancer Inst. 1991 Apr 17;83(8):569-75. doi: 10.1093/jnci/83.8.569.
4
Nodal CT density and total tumor volume as prognostic factors after radiation therapy of stage III/IV head and neck cancer.Ⅲ/Ⅳ期头颈部癌放疗后,淋巴结CT密度和肿瘤总体积作为预后因素。
Radiother Oncol. 1998 May;47(2):175-83. doi: 10.1016/s0167-8140(98)00016-4.
5
The prognostic value of location and size change of pathological lymph nodes evaluated on CT-scan following radiotherapy in head and neck cancer.头颈部癌放疗后CT扫描评估病理性淋巴结位置及大小变化的预后价值
Cancer Imaging. 2017 Feb 28;17(1):8. doi: 10.1186/s40644-017-0111-y.
6
Control of nodal metastases in squamous cell head and neck cancer treated by radiation therapy or chemoradiation.放射治疗或放化疗治疗的头颈部鳞状细胞癌区域淋巴结转移的控制
Radiother Oncol. 2006 Apr;79(1):39-44. doi: 10.1016/j.radonc.2006.03.008.
7
Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.治疗前 18F-FDG PET/CT 最大标准化摄取值对局部晚期头颈部鳞状细胞癌的预后价值。
Clin Transl Oncol. 2017 Nov;19(11):1337-1349. doi: 10.1007/s12094-017-1674-6. Epub 2017 May 24.
8
Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas.与其他头颈部鳞状细胞癌的淋巴结转移相比,鼻咽癌引起的颈部淋巴结转移通过放疗的控制效果更佳。
Int J Radiat Oncol Biol Phys. 1997 Aug 1;39(1):149-54. doi: 10.1016/s0360-3016(97)00313-1.
9
Impact of tumor control and presence of visible necrosis in head and neck cancer patients treated with radiotherapy or radiochemotherapy.放疗或放化疗治疗的头颈癌患者中肿瘤控制及可见坏死情况的影响
J Cancer Res Clin Oncol. 2005 Nov;131(11):758-64. doi: 10.1007/s00432-005-0018-z. Epub 2005 Nov 1.
10
Correlation between computed tomographic density of lymph node metastases and response to cisplatin-based chemotherapy in patients with head and neck squamous cell carcinoma in an area in which betel quid chewing is prevalent.
Cancer. 1996 Nov 1;78(9):1972-9. doi: 10.1002/(sici)1097-0142(19961101)78:9<1972::aid-cncr19>3.0.co;2-v.

引用本文的文献

1
Combined chemoradiotherapy with local microwave hyperthermia for treatment of T3N0 laryngeal carcinoma: a retrospective study with long-term follow-up.联合放化疗与局部微波热疗治疗T3N0期喉癌:一项长期随访的回顾性研究
Acta Otorhinolaryngol Ital. 2014 Jun;34(3):167-73.
2
Inducible promoters for gene therapy of head and neck cancer: an in vitro study.
Eur Arch Otorhinolaryngol. 2004 Apr;261(4):208-15. doi: 10.1007/s00405-003-0621-z. Epub 2003 Aug 12.